Axon Enterprise
AXON
#539
Rank
A$65.70 B
Marketcap
A$832.64
Share price
0.06%
Change (1 day)
-17.07%
Change (1 year)

P/E ratio for Axon Enterprise (AXON)

P/E ratio as of December 2025 (TTM): 165

According to Axon Enterprise 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 165.034. At the end of 2024 the company had a P/E ratio of 120.

P/E ratio history for Axon Enterprise from 2002 to 2025

PE ratio at the end of each year

Year P/E ratio Change
20241208.32%
202311037.72%
202280.2-147.48%
2021-169-94.49%
2020< -1000-141.8%
2019> 10008777.35%
201882.5-68.85%
2017265249.83%
201675.766.48%
201545.5-36.42%
201471.671.26%
201341.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
XBiotech
XBIT
-3.14-101.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-1.13-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
17.8-89.23%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.